Innophos Stock Price, News & Analysis (NASDAQ:IPHS)

$33.34
-1.10 (-3.19 %)
(As of 09/22/2019 06:19 AM ET)
Today's Range
$33.05
Now: $33.34
$34.70
50-Day Range
$24.12
MA: $28.43
$34.53
52-Week Range
$22.57
Now: $33.34
$46.65
Volume145,615 shs
Average Volume111,950 shs
Market Capitalization$656.46 million
P/E Ratio16.25
Dividend Yield5.57%
Beta1.43
Innophos Holdings, Inc, together with its subsidiaries, produces specialty ingredients with applications in food, health, nutrition, and industrial markets. It operates through three segments: Food, Health and Nutrition; Industrial Specialties; and Other. The company's specialty ingredients include specialty phosphate salts and specialty phosphoric acids, as well as other mineral, enzyme, and botanical based specialty ingredients that are used as flavor enhancers in beverages; electrolytes in sports drinks; texture modifiers in cheeses; leavening agents in baked goods; calcium and phosphorus fortification in food and beverages; moisture and color retention in seafood, poultry, and meat; excipients in vitamins, minerals, nutritional supplements, and pharmaceuticals; and abrasives in toothpaste. Read More…

Industry, Sector and Symbol

Industry Chemicals & allied products
Sub-IndustrySpecialty Chemicals
SectorBasic Materials
Current SymbolNASDAQ:IPHS
CUSIP45774N10
Phone609-495-2495

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$801.84 million
Cash Flow$4.4632 per share
Book Value$17.10 per share

Profitability

Net Income$36.07 million

Miscellaneous

Employees1,485
Market Cap$656.46 million
Next Earnings Date11/7/2019 (Estimated)
OptionableOptionable

Receive IPHS News and Ratings via Email

Sign-up to receive the latest news and ratings for IPHS and its competitors with MarketBeat's FREE daily newsletter.


Innophos (NASDAQ:IPHS) Frequently Asked Questions

What is Innophos' stock symbol?

Innophos trades on the NASDAQ under the ticker symbol "IPHS."

How often does Innophos pay dividends? What is the dividend yield for Innophos?

Innophos declared a quarterly dividend on Tuesday, August 6th. Stockholders of record on Friday, August 23rd will be paid a dividend of $0.48 per share on Friday, September 6th. This represents a $1.92 dividend on an annualized basis and a dividend yield of 5.76%. The ex-dividend date is Thursday, August 22nd. View Innophos' Dividend History.

How were Innophos' earnings last quarter?

Innophos Holdings, Inc. (NASDAQ:IPHS) released its quarterly earnings data on Tuesday, August, 6th. The specialty chemicals company reported $0.43 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.37 by $0.06. The specialty chemicals company had revenue of $185.04 million for the quarter, compared to analyst estimates of $196.55 million. Innophos had a net margin of 3.79% and a return on equity of 12.35%. The firm's revenue was down 10.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.55 EPS. View Innophos' Earnings History.

When is Innophos' next earnings date?

Innophos is scheduled to release their next quarterly earnings announcement on Thursday, November 7th 2019. View Earnings Estimates for Innophos.

What guidance has Innophos issued on next quarter's earnings?

Innophos updated its FY 2019 earnings guidance on Tuesday, August, 6th. The company provided EPS guidance of for the period. The company issued revenue guidance of $745.86-753.88 million, compared to the consensus revenue estimate of $786.67 million.

What is the consensus analysts' recommendation for Innophos?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Innophos in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Innophos.

Has Innophos been receiving favorable news coverage?

Media headlines about IPHS stock have been trending somewhat negative this week, InfoTrie reports. The research group identifies positive and negative press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Innophos earned a daily sentiment score of -1.3 on InfoTrie's scale. They also gave media coverage about the specialty chemicals company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for Innophos.

Are investors shorting Innophos?

Innophos saw a increase in short interest in the month of August. As of August 31st, there was short interest totalling 386,000 shares, an increase of 14.6% from the July 31st total of 336,700 shares. Based on an average daily trading volume, of 74,000 shares, the days-to-cover ratio is currently 5.2 days. Approximately 2.0% of the company's shares are sold short. View Innophos' Current Options Chain.

Who are some of Innophos' key competitors?

What other stocks do shareholders of Innophos own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Innophos investors own include Applied Materials (AMAT), Intel (INTC), Freeport-McMoRan (FCX), 3M (MMM), Allena Pharmaceuticals (ALNA), Costco Wholesale (COST), FireEye (FEYE), Xperi (XPER), Alibaba Group (BABA) and Delek US (DK).

Who are Innophos' key executives?

Innophos' management team includes the folowing people:
  • Dr. Kim Ann Mink, Chairman, CEO & Pres (Age 59)
  • Mr. Hermanus Kieftenbeld, Sr. VP & CFO (Age 53)
  • Ms. Sherry Duff, Sr. VP and Chief Marketing & Technology Officer (Age 51)
  • Mr. Joshua Horenstein, Sr. VP, Chief Legal Officer & Corp. Sec. (Age 42)
  • Ms. Amy Hartzell, Sr. VP of Supply Chain & Purchasing (Age 43)

Who are Innophos' major shareholders?

Innophos' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (15.09%), Vanguard Group Inc. (10.98%), Renaissance Technologies LLC (4.41%), Investment Counselors of Maryland LLC (3.08%), Bank of New York Mellon Corp (2.77%) and Deprince Race & Zollo Inc. (2.27%). View Institutional Ownership Trends for Innophos.

Which institutional investors are selling Innophos stock?

IPHS stock was sold by a variety of institutional investors in the last quarter, including Bank of America Corp DE, Citadel Advisors LLC, Deprince Race & Zollo Inc., D. E. Shaw & Co. Inc., Morgan Stanley, Wells Fargo & Company MN, Dalton Greiner Hartman Maher & Co. and SG Americas Securities LLC. View Insider Buying and Selling for Innophos.

Which institutional investors are buying Innophos stock?

IPHS stock was bought by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Nuveen Asset Management LLC, Vanguard Group Inc., Bank of New York Mellon Corp, BlackRock Inc., Susquehanna International Group LLP, Penn Capital Management Co. Inc. and Pinebridge Investments L.P.. View Insider Buying and Selling for Innophos.

How do I buy shares of Innophos?

Shares of IPHS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Innophos' stock price today?

One share of IPHS stock can currently be purchased for approximately $33.34.

How big of a company is Innophos?

Innophos has a market capitalization of $656.46 million and generates $801.84 million in revenue each year. The specialty chemicals company earns $36.07 million in net income (profit) each year or $2.28 on an earnings per share basis. Innophos employs 1,485 workers across the globe.View Additional Information About Innophos.

What is Innophos' official website?

The official website for Innophos is http://www.innophos.com/.

How can I contact Innophos?

Innophos' mailing address is 259 PROSPECT PLAINS ROAD, CRANBURY NJ, 08512. The specialty chemicals company can be reached via phone at 609-495-2495 or via email at [email protected]


MarketBeat Community Rating for Innophos (NASDAQ IPHS)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  311 (Vote Outperform)
Underperform Votes:  299 (Vote Underperform)
Total Votes:  610
MarketBeat's community ratings are surveys of what our community members think about Innophos and other stocks. Vote "Outperform" if you believe IPHS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IPHS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel